Previous 10 | Next 10 |
SAN DIEGO, Sept. 13, 2022 (GLOBE NEWSWIRE) -- TriLink BioTechnologies (TriLink), a Maravai LifeSciences company (Maravai) (NASDAQ: MRVI) and global provider of life science reagents and services, has expanded its GMP-grade product offering to include N1-Methyl-Pseudouridine-5’-Tr...
Summary Bruker Corporation has done alright from an operational perspective, with sales continuing to rise modestly this year. Foreign currency is an issue right now and profits have contracted, posing investors some risk. Although shares are getting cheaper, they do still loo...
SAN DIEGO, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conferences during the month of September. ...
Maravai LifeSciences Holdings, Inc. (MRVI) Q2 2022 Earnings Conference Call August 4, 2022 5:00 PM ET Company Participants Deb Hart - Head of Investor Relations Carl Hull - Chief Executive Officer Kevin Herde - Chief Financial Officer Conference Call Partic...
The following slide deck was published by Maravai LifeSciences Holdings, Inc. in conjunction with their 2022 Q2 earnings call. For further details see: Maravai LifeSciences Holdings, Inc. 2022 Q2 - Results - Earnings Call Presentation
Image source: The Motley Fool. Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) Q2 2022 Earnings Call Aug 04, 2022 , 5:00 p.m. ET Operator Continue reading For further details see: Maravai LifeSciences Holdings, Inc. (MRVI) Q2 2022 Earn...
Entering August, the bear market looks destined to continue, especially with inflation remaining high and the U.S. economy contracting for a second straight quarter. That likely means the bearishness in stocks isn't going away just yet. But if you're a long-term investor, that also means yo...
Maravai LifeSciences came in with another strong quarter with upsides at the top and bottom line against consensus. Profitability continued to shine this quarter and the company recognized a normalized quarterly return on invested capital of 18% since listing. Despite the strength...
SAN DIEGO, Aug. 04, 2022 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today, August 4 th , by Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), please note that a variety of changes have been made throughout the release. These includes the wording ...
Maravai LifeSciences Holdings press release ( NASDAQ: MRVI ): Q2 GAAP EPS of $0.53 beats by $0.15 . Revenue of $242.73M (+11.5% Y/Y) beats by $9.51M . Shares -4.98% . For further details see: Maravai LifeSciences Holdings GAAP EPS of $0.53 beats b...
News, Short Squeeze, Breakout and More Instantly...
Maravai LifeSciences Holdings Inc. Company Name:
MRVI Stock Symbol:
NASDAQ Market:
Maravai LifeSciences Holdings Inc. Website:
2024-07-25 20:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
SAN DIEGO, July 10, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its second quarter 2024 financial and operating results after the market closes on...
- Highlights progress across four priority areas and commitment to environmentally and socially responsible growth. - Conducted first stakeholder assessment to identify and prioritize ESG issues that are most important for Maravai and our stakeholders. - Increased the sc...